tiprankstipranks
Trending News
More News >
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market
Advertisement

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Price & Analysis

Compare
1 Followers

2315 Stock Chart & Stats


Financials

2315 FAQ

What was Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s price range in the past 12 months?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H lowest stock price was HK$5.60 and its highest was HK$24.15 in the past 12 months.
    What is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s market cap?
    Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s market cap is HK$8.47B.
      When is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s upcoming earnings report date?
      Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s upcoming earnings report date is Sep 02, 2025 which is in 45 days.
        How were Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s earnings last quarter?
        Currently, no data Available
        Is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H overvalued?
        According to Wall Street analysts Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H pay dividends?
          Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H does not currently pay dividends.
          What is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s EPS estimate?
          Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s EPS estimate is 0.01.
            How many shares outstanding does Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H have?
            Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H has 110,781,920 shares outstanding.
              What happened to Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H?
              Currently, no hedge funds are holding shares in HK:2315

              Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Stock Smart Score

              Company Description

              Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H

              Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of antibody-based drugs worldwide. The company's pipeline includes 12 core products, among which two products are in Phase II multi-regional clinical trials and two products are in Phase I clinical trials. It focuses on developing drugs in the areas of oncology, autoimmune, inflammatory, metabolic, and other diseases. The company was founded in 2009 and is headquartered in Beijing, China. Beijing Biocytogen Co., Ltd. develops and prepares gene engineered animals to large-scale supply of animal models. It offers preclinical animal studies using gene humanized models, PDX models, and human immune system reconstruction models. The company's products include B-NDG mice, cre mouse models, cre rat models, B-p53 KO mice, B-ApoE KO mice, B-hIL6 mice, B-IL17-EGFP KI mice, B-TGFb1 cKO mice, genome- edited hESC, luciferase reported stable tumor cell lines, B-Pink1 KO rats, B-IL2rg KO rats, B-Cas9D10A cKI rats, B-ApoA4 KO rats, B-LDLR KO rats, B-Prkdc KO rats, B-Rag2 KO rats, B-tdTomato cKI rats, B-ApoE KO rats, B-hTnf mice, and B-hFcgrt (FcRn) mice. Beijing Biocytogen Co., Ltd. also develops antibody research and development platform and provides pharmacology services in the areas of tumor immunity, tumor and autoimmunity, and in vivo and in vitro pharmacology and pharmacology service platform. It also sells its products online. The company was founded in 2008 and is based in Beijing, China with additional locations in Beijing, Haimen, Jiangsu, Shanghai, China; Heidelberg, Germany; and Boston, the United States.
              Similar Stocks
              Company
              Price & Change
              Follow
              Ascletis Pharma, Inc.
              Lepu Biopharma Co. Ltd. Class H
              Keymed Biosciences, Inc.
              CARsgen Therapeutics Holdings Ltd.
              Shandong Boan Biotechnology Company., Limited. Class H
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis